Recent articles

Read the inspiring story of the Teske family and their journey with type 1 diabetes. Learn how their dedication to advocacy and estate planning supports Breakthrough T1D's mission to fund critical research and find a cure.

A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body, and its expression is limited to tissues that require sugar-sensing, mainly the liver and pancreatic beta cells. If blood glucose levels are deemed too high, activation of GK in the liver increases glucose utilization which in turn lowers blood glucose.

The Breakthrough T1D Young Adult Conference is right around the corner. We’re thrilled to announce the following speakers and we can’t wait to see you in Dallas on March 30th and 31st. Haven’t signed up to attend? Registration is open until February 28th. Brandon Arbiter: Brandon is the VP, Product and Business Development for Tidepool. He […]

You’ll hear it again and again: For some people with type 1 diabetes (T1D), SGLT inhibitor therapy* means taking less insulin, having increased time in range, reducing the minute-to-minute glucose variability, contributing to weight loss and lowering your A1c. But you’ll also hear about the risks. From dehydration and constant urination to urinary tract infections […]

Starting on January 31, Breakthrough T1D Ambassador Eric Tozer will be participating in the 2019 World Marathon Challenges–7 marathons in 7 days on 7 continents. But unlike every other person who has taken on this ultimate test of endurance to date, Eric, a native of San Diego, will be one of the first people with […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.